ID: ALA3246763

Max Phase: Preclinical

Molecular Formula: C6H9N5O

Molecular Weight: 167.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CNc2nc(N)[nH]c(=O)c21

Standard InChI:  InChI=1S/C6H9N5O/c1-11-2-8-4-3(11)5(12)10-6(7)9-4/h2H2,1H3,(H4,7,8,9,10,12)

Standard InChI Key:  DZHHXMZCVDTUBX-UHFFFAOYSA-N

Associated Targets(Human)

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 167.17Molecular Weight (Monoisotopic): 167.0807AlogP: -0.83#Rotatable Bonds: 0
Polar Surface Area: 87.04Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.81CX Basic pKa: 1.10CX LogP: -0.98CX LogD: -1.11
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.47Np Likeness Score: 0.17

References

1. Jordan F, Wu A..  (1978)  Stereoelectronic factors in the binding of substrate analogues and inhibitors to purine nucleoside phosphorylase isolated from human erythrocytes.,  21  (9): [PMID:31484] [10.1021/jm00207a008]

Source